NDC Package 42291-453-60 Cilostazol

View Billable Units, 11-Digit Format, RxNorm

Package Information
Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing expired due to lack of listing certification.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

42291-453-60

Package Description:

60 TABLET in 1 BOTTLE

Product Code:

42291-453

Proprietary Name:

Cilostazol

Usage Information:

Cilostazol is used to improve the symptoms of a certain blood flow problem in the legs (intermittent claudication). Cilostazol can decrease the muscle pain/cramps that occur during exercise/walking. Claudication pain is caused by too little oxygen getting to the muscles. Cilostazol can increase blood flow and the amount of oxygen that gets to the muscles. Cilostazol is an antiplatelet drug and a vasodilator. It works by stopping blood cells called platelets from sticking together and prevents them from forming harmful clots. It also widens blood vessels in the legs. Cilostazol helps the blood to move more easily and keeps blood flowing smoothly in your body.

11-Digit NDC Billing Format:

42291045360

Billing Unit:

EA - Billing unit of "each" is used when the product is dispensed in discreet units.

NDC to RxNorm Crosswalk:

60 EA

NDC to RxNorm Crosswalk:

RxCUI: 242461 - cilostazol 100 MG Oral Tablet

Labeler Name:

Avkare

Sample Package:

FDA Application Number:

ANDA077030

Marketing Category:

ANDA - A product marketed under an approved Abbreviated New Drug Application.

Start Marketing Date:

04-12-2022

Listing Expiration Date:

12-31-2025

Exclude Flag:

Code Structure:

42291 - Avkare
- 42291-453 - Cilostazol
  - 42291-453-60 - 60 TABLET in 1 BOTTLE

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 42291-453-60?

The NDC Packaged Code 42291-453-60 is assigned to a package of 60 tablet in 1 bottle of Cilostazol, labeled by Avkare. The product's dosage form is and is administered via form.This product is billed for "EA" each discreet unit and contains an estimated amount of 60 billable units per package.

Is NDC 42291-453 included in the NDC Directory?

No, Cilostazol with product code 42291-453 is excluded from the NDC Directory because it's listing has EXPIRED due to lack of listing certification. The product was first marketed by Avkare on April 12, 2022 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 42291-453-60?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 60.

What is the 11-digit format for NDC 42291-453-60?

The 11-digit format is 42291045360. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	42291-453-60	5-4-2	42291-0453-60

Table of Contents